J. Safra Asset Management’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.88K Sell
373
-77
-17% -$1.48K ﹤0.01% 414
2026
Q1
$7.93K Buy
450
+384
+582% +$7.71K ﹤0.01% 395
2025
Q4
$1.3K Buy
+66
New +$1.19K ﹤0.01% 612
2025
Q3
– Sell
-250
Closed -$3.5K – 472
2025
Q2
$3.5K Sell
250
-78
-24% -$1.26K ﹤0.01% 332
2025
Q1
$6.11K Buy
328
+277
+543% +$4.13K ﹤0.01% 307
2024
Q4
$569 Hold
51
– – ﹤0.01% 321
2024
Q3
$585 Buy
+51
New +$482 ﹤0.01% 284

Other funds holding ALHC

J. Safra Asset Management's ALHC Position: Q2 2026 in Review

J. Safra Asset Management reduced its Alignment Healthcare (ALHC) stake by 17% in Q2 2026, selling an estimated $1.48K and leaving 373 shares worth $8.88K. The position accounts for ﹤0.01% of the portfolio, ranked #414.

J. Safra Asset Management first reported a position in ALHC in Q3 2024 and has held it in 7 quarters since. 324 funds tracked by Wall St. Rank hold ALHC as of Q2 2026.

  • J. Safra Asset Management held 373 shares of Alignment Healthcare worth $8.88K as of Q2 2026.
  • J. Safra Asset Management sold 77 Alignment Healthcare shares in Q2 2026, an estimated $1.48K.
  • Alignment Healthcare made up ﹤0.01% of J. Safra Asset Management's portfolio in Q2 2026, its #414 holding.
  • J. Safra Asset Management first reported a position in Alignment Healthcare in Q3 2024 and has held it in 7 quarters since.
  • 324 funds tracked by Wall St. Rank held Alignment Healthcare as of Q2 2026.

Based on J. Safra Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.